Skip to Content
Søk Menu

CheckMate 9LA – Investigating the role of immunotherapy combinations in patients with non-small cell lung cancer

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relateret indhold

Edyta Maria Urbanska

New Tendencies in Development of ALK-TKIs for Treatment of ALK-Rearranged NSCLC

/ Edyta Maria Urbanska
Lungekreft Play the Video 13:31
Oluf Dimitri Røe

ASCO24: Very Exciting Steps for Early Diagnosis and Lung Cancer

/ Oluf Dimitri Røe
ASCO24Lungekreft Play the Video 6:15
Edyta Maria Urbanska

Younger Patients with Lung Cancer Treated with ALK Tyrosine Kinase Inhibitors Seem to be Prone to Return to Work

/ Edyta Maria Urbanska
Lungekreft Play the Video 5:45
Christina H. Ruhlmann

Updated MASCC/ESMO Guidelines on Prevention of Cancer Therapy-Induced Nausea and Vomiting

/ Christina H. Ruhlmann
BehandlingKjemoterapiKreft Play the Video 7:41
Vivi Quoc Nguyen

Carboplatin is a Viable Option in Treating Patients with Completely Resected Non-Small Cell Lung Cancer

/ Vivi Quoc Nguyen
Lungekreft Play the Video 1:44
Odd Terje Brustugun

Onkologisk Forum: Highlights in Lung Cancer Treatment

/ Odd Terje Brustugun
LungekreftOnkologiskForum23 Play the Video 5:22
Nathan Harrison

Interventions Designed to Reduce Lung Cancer Stigma

/ Nathan Harrison
LungekreftWCLC23 Play the Video 7:15
Jonathan Spicer

Perioperative Pembrolizumab Shows Significant OS in ResectableNon-Small-Cell Lung Cancer

/ Jonathan Spicer
ESMO23Lungekreft Play the Video 4:01
Masahiro Tsuboi

Efficacy of Osimertinib in resected EGFR-Mutated stage IB-IIIA NSCLC

/ Masahiro Tsuboi
Lungekreft Play the Video 7:07
Back to top